Appili Therapeutics Inc. (TSE:APL) to Post FY2023 Earnings of ($0.09) Per Share, Zacks Small Cap Forecasts
Appili Therapeutics Inc. (TSE:APL) to Post FY2023 Earnings of ($0.09) Per Share, Zacks Small Cap Forecasts
Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap boosted their FY2023 earnings estimates for shares of Appili Therapeutics in a note issued to investors on Thursday, September 1st. Zacks Small Cap analyst D. Bautz now anticipates that the company will post earnings per share of ($0.09) for the year, up from their previous estimate of ($0.10).
Appili治疗公司(多伦多证券交易所股票代码:APL-GET评级)--在9月1日星期四发给投资者的一份报告中,Zack Small Cap的股票研究人员上调了他们对Appili治疗公司股票2023财年的收益预期。扎克斯小盘分析师D.Bautz现在预计,该公司今年的每股收益将为0.09美元,高于此前预测的0.10美元。
Appili Therapeutics (TSE:APL – Get Rating) last issued its quarterly earnings data on Friday, August 12th. The company reported C($0.03) earnings per share (EPS) for the quarter, hitting the consensus estimate of C($0.03). The business had revenue of C$0.01 million for the quarter.
Appili Treateutics(多伦多证券交易所股票代码:APL-GET Rating)最近一次发布季度收益数据是在8月12日星期五。该公司公布本季度每股收益(EPS)为0.03加元,超过了普遍预期的0.03加元。该业务本季度的收入为10万加元。
Appili Therapeutics Stock Performance
阿普利治疗公司股票表现
Further Reading
进一步阅读
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 随着管理层重组,股市能否迅速反弹?
- MarketBeat:回顾中的一周8/29-9/2
- 霍梅尔在这些水平上看起来很便宜
- 露露柠檬将飙升至9月
- 耐克股票会被超卖,但仍被高估吗?
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
获得《阿普利治疗日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Appili Treateutics和相关公司的最新新闻和分析师评级的每日简要摘要。